Key stats
- Market cap
- 176B
- Open
- —
- Day range
- —
- 52-week range
- $23.62 – $31.06
- Volume
- 4.33M
- Avg volume
- 30.8M
Q3 FY26Beat
Expected$0.73
Actual$0.87
PFE
Pfizer Inc$30.87+$0.20+0.65%Price as of Nov 3, 2026, 9:18 AM ET
Earnings
Q2 FY26
Actual$-0.04
Q1 FY26
Actual$0.47
Q4 FY25
Actual$-0.29
About
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
- Employees
- 75,000
- Headquarters
- New York, NY